Profilo
Daniela Carmen Oniciu is the founder of Creative Pharma Advisors LLC.
She worked as an Associate Director-Chemistry at Pfizer Inc. from 2004 to 2008.
Prior to that, she was a Senior Director-Chemical Research & Development at Esperion Therapeutics, Inc. from 2001 to 2004.
From 2005 to 2014, she held the position of Senior Director-Chemistry at ABIONYX Pharma SA. Later, she served as the Vice President-Preclinical Research & Development at Gemphire Therapeutics, Inc. from 2014 to 2018.
In addition to her former jobs, she also worked as the Chief Operating Officer at BioSavita, Inc. and as the Head-Research & Development at Ocuphire Pharma, Inc. Dr. Oniciu obtained her graduate and doctorate degrees from Politehnica University of Bucharest.
Precedenti posizioni note di Daniela Oniciu
| Società | Posizione | Fine |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 31/12/2023 |
| NEUROBO PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2018 |
| ABIONYX PHARMA | Corporate Officer/Principal | 01/02/2014 |
| PFIZER, INC. | Corporate Officer/Principal | 01/02/2008 |
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2004 |
Formazione di Daniela Oniciu
| Politehnica University of Bucharest | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| PFIZER, INC. | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| ABIONYX PHARMA | Health Technology |
| OCUPHIRE PHARMA, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
BioSavita, Inc.
 BioSavita, Inc. BiotechnologyHealth Technology BioSavita, Inc. operates as a biotechnology company, which develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company was founded by Nalini Ghag-Motwani in 1993 and is headquartered in Plymouth, MI. | Health Technology |
| Creative Pharma Advisors LLC |
- Borsa valori
- Insiders
- Daniela Oniciu
